ATH 0.00% 0.3¢ alterity therapeutics limited

Ann: PBT434 Lowers Alpha-Synuclein and Prevents Neurodegeneration, page-16

  1. 192 Posts.
    lightbulb Created with Sketch. 50
    ITM...where have you been? welcome back...your thoughts about PBT 434 now being at the forefront (lead drug candidate?!) in terms of Prana's focus and PBT 2 apparently on the back burner for the time being? The new process and wait begins for us old investors!
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $4.579K 1.526M

Buyers (Bids)

No. Vol. Price($)
1 574591 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 133062022 26
View Market Depth
Last trade - 14.03pm 13/09/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.